“Ryder System, Inc. (NYSE: R): Complete Investment Review”
Learn about the recent performance of Ryder System, Inc., a major logistics and transportation company that's showing strong growth prospects despite a minor stock dip. Excellent financial health and significant projected stock price increase make Ryder an attractive option for growth-focused investors. Read more
Read More
“Ardelyx Gets Strong Buy Nod from Raymond James Amid Drug Price Hike”
Raymond James reiterates a Strong Buy rating for the biopharmaceutical company, Ardelyx, maintaining a $16 price target. Encouraging trends in the increased usage of Ardelyx's key products Xphozah and Ibsrela, and recent price hikes, have prompted Raymond James' positive review. Read more
Read More“Ardelyx Gets Raymond James’ Strong Buy Rating After Drug Price Hike”
Raymond James reasserts its Strong Buy rating for biopharmaceutical company Ardelyx, amidst price increases for essential products, Xphozah and Ibsrela. This optimism reflects the growing consumer utilization trend, promising future growth, and a potential boost in Ardelyx's overall financial performance. Read more
Read More